ScholarLens Back to search
1990•Drug and Therapeutics BulletinRequires access

Three new non-sedative antihistamines: worth keeping an eye open for

Author information unavailable

Open publisher page 1 citations

Abstract

Oral antihistamines are used to relieve symptoms in allergic rhinitis, conjunctivitis, urticaria and eczema. Traditional H1 receptor antagonists have sedative, and in some cases anticholinergic, side effects. A significant advance has been the development of more specific H1 antagonists in which these other properties are greatly reduced. Terfenadine and astemizole were the first;1 acrivastine (Semprex - Wellcome), cetirizine (Zirtek - A&H) and loratadine (Clarityn - Schering Plough) are three newer ones. Are they better than terfenadine and astemizole?

About this research paper

What this paper is about

Oral antihistamines are used to relieve symptoms in allergic rhinitis, conjunctivitis, urticaria and eczema. Traditional H1 receptor antagonists have sedative, and in some cases anticholinergic, side effects. A significant advance has been the development of more specific H1 antagonists in which these other properties are greatly reduced. Terfenadine and astemizole were the first;1 acrivastine (Semprex - Wellcome), cetirizine (Zirtek - A&H) and loratadine (Clarityn - Schering Plough) are three newer ones. Are they better than terfenadine and astemizole?

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Oral antihistamines are used to relieve symptoms in allergic rhinitis, conjunctivitis, urticaria and eczema. Traditional H1 receptor antagonists have sedative, and in some cases anticholinergic, side effects. A significant advance has been the development of more specific H1 antagonists in which these other properties are greatly reduced. Terfenadine and astemizole were the first;1 acrivastine (Semprex - Wellcome), cetirizine (Zirtek - A&H) and loratadine (Clarityn - Schering Plough) are three newer ones. Are they better than terfenadine and astemizole?

Key concepts: Astemizole, Terfenadine, Loratadine, Cetirizine, Medicine, Anticholinergic, Sedative, Antihistamine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Three new non-sedative antihistamines: worth keeping an eye open for — Research Paper | ScholarLens